Praxis Medical Insights

Pathophysiology and Treatment Approach

Diuretics are the cornerstone treatment for managing extracellular space edema caused by steroid-related fluid retention, with loop diuretics being the first-line therapy, as recommended by the American College of Cardiology and the American Heart Association 1, 2

Determine if edema is due to intravascular fluid overload or other causes to guide treatment approach, and monitor electrolytes, renal function, and signs of hypovolemia, as suggested by the American College of Cardiology 3, 4

The American College of Cardiology recommends furosemide (initial dose 20-40 mg once or twice daily, maximum 600 mg daily) as a first-line therapy for edema 2
The American College of Cardiology also recommends bumetanide (initial dose 0.5-1.0 mg once or twice daily, maximum 10 mg daily) and torsemide (initial dose 10-20 mg once daily, maximum 200 mg daily) as alternative first-line therapies for edema 2
For diuretic resistance, consider sequential nephron blockade by combining a loop diuretic with metolazone (2.5-10 mg once daily) or hydrochlorothiazide (25-100 mg once or twice daily), as recommended by the American College of Cardiology 2

Restrict dietary sodium (to 2 g daily or less) to assist in maintaining volume balance, as recommended by the American Heart Association 4
Consider fluid restriction to 2 liters daily in patients with persistent fluid retention, as suggested by the American Heart Association 4
Monitor daily weights to guide diuretic dosage adjustments, as recommended by the American College of Cardiology 3
Do not be excessively concerned about mild hypotension or azotemia, as this can lead to underutilization of diuretics and persistent edema, as noted by the American College of Cardiology and the American Heart Association 3, 4